¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mean life"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mean effective dose
    Æò±ÕÀ¯È¿¼±·®
  • mean lethal dose
    1. Æò±ÕÄ¡»ç¿ë·® 2. Æò±ÕÄ¡»ç¼±·®
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • mean solar day
    Æò±ÕžçÀÏ
  • mean tidal time
    Æò±Õ¼øÈ¯½Ã°£
  • mean venous oxygen content
    Æò±ÕÁ¤¸ÆÇ÷»ê¼Ò·®
  • population mean
    ¸ðÁý´ÜÆò±Õ
  • progressive mean
    ´©°¡Æò±Õ
  • sylvatic life cycle
    ¾ß»ý»ýȰÁÖ±â
  • shelf life
    ÀúÀå±â°£, º¸°ü±â°£
  • simple arithmetic mean
    ´Ü¼ø»ê¼úÆò±Õ
  • weighted arithmetic mean
    °¡Áß»ê¼úÆò±Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mean deviation
    Æò±ÕÆíÂ÷
  • mean corpuscular diameter
    Æò±ÕÀûÇ÷±¸Áö¸§
  • mean effective dose
    Æò±ÕÀ¯È¿¼±·®
  • mean lethal dose
    Æò±ÕÄ¡»ç·®, Æò±ÕÄ¡»ç¼±·®
  • mean solar day
    Æò±ÕžçÀÏ
  • root mean square deviation
    Á¦°ö±ÙÆò±ÕÁ¦°öÆíÂ÷
  • geometric mean
    ±âÇÏÆò±Õ
  • mean corpuscular hemoglobin
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò·®
  • mean
    Æò±Õ
  • mean arterial blood pressure
    Æò±Õµ¿¸Æ¾Ð
  • mean blood pressure
    Æò±ÕÇ÷¾Ð
  • mean corpuscular thickness
    Æò±ÕÀûÇ÷±¸µÎ²²
  • mean corpuscular volume
    Æò±ÕÀûÇ÷±¸¿ëÀû
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • mean spatial vector
    Æò±Õ°ø°£º¤ÅÍ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mean deviation
    Æò±ÕÆíÂ÷(ÊṴ̤̀).
  • mean dispersion
    Æò±ÕºÐ»ê(ÊÙËÓË×).
  • mean effective dose =median e. d.
    50% À¯È¿·®(¡­êóüùåÖ).
  • mean electrical axis
    Æò±ÕÀü±âÃà(øÁгï³Ñ¨õî).
  • mean error
    Æò±Õ¿ÀÂ÷(̰˻Ëí̤).
  • mean lethal dose =LD50
    50% Ä¡»ç·® (¡­öÈÞÝåÖ).
  • mean lethal dose, Do
    Æò±ÕÄ¡»ç¼±·®
  • mean molecular weight
    Æò±ÕºÐÀÚ·® (¡­ÝÂí­åÖ).
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • mean platelet volume=MPV
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • mean proportional
    ºñ·ÊÁßÇ×(ËÓËç̴̡).
  • mean solar day
    Æò±ÕžçÀÏ(̰˻̬ËâËö).
  • mean spatial vector
    Æò±Õ°ø°£(øÁгÍöÊà) º¤ÅÍ.
  • mean survival time
    Æò±Õ»ýÁ¸½Ã°£(̰˻Ë×Ì¡Ëà˧).
  • mean target dose
    Æò±ÕÇ¥Àû¼±·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ALTE Apparent Life-Threatening Event; »ý¸í À§Çù »ç°Ç
  = Near Miss
  ; È£Èí Á¤Áö¿Í ºó¸Æ, û»ö...
BLS Basic Life Support
HL Half Life
Tb biologic Half-Life
Te effective Half-Life
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CELSS Controlled Ecological Life Support System
DLQI Dermatology Life Quality Index
DALY Disability Adjusted Life Year
ECLS Extra Corporeal Life Support
ELSO Extracorporeal Life Support Organization
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fatigue life
    ÇÇ·Î ¼ö¸í
    ÇÇ·Î Æò°¡¹ýÀÇ Çϳª. ¹Ýº¹ ÀÀ·ÂÀÌ ÀÏÁ¤ÇÒ ¶§¿¡ ÆÄ±«¸¦ ÀÏÀ¸Å°´Â ÃÖ¼ÒÀÇ ¹Ýº¹ Ƚ¼ö.
  • half-life of immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ¹Ý°¨±â
  • life
    »ý¸í
    »ý¸í Çö»óÀÇ ÃÑĪ. À¯±âü°¡ ¹«±â¹°°ú´Â °ü°è¾ø´Â ÈûÀ̳ª ±â´ÉÀ» ³ªÅ¸³»´Â °æ¿ìÀÇ ¸·¿¬ÇÑ °³³ä. ÀϹÝÀûÀ¸·Î »ý¸íü´Â ¿©·¯ °¡Áö Á¤µµÀÇ Â÷ÀÌ´Â ÀÖÀ¸³ª ±â±¸È­, ÇÇÀڱؼº, ¿îµ¿, ¹ßÀ°, »ý½Ä, ÀûÀÀ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù.
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
    »ý¹°ÀÇ »ýȰ»ç¿¡ ÀÖ¾î ÀÏ·ÃÀÇ Çö»ó.
  • life expectancy
    ¼ö¸í
    ¾î¶² ¿¬·É ¶Ç´Â ¿¬·ÉÃþÀÇ »ç¶÷ÀÌ ´õ »ì ¼ö ÀÖ´Â °¡´É¼ºÀÌ ÀÖ´Â ¿¬¼ö·Î¼­ Åë°èÀûÀÎ Æò±Õ¿¡ ±âÃÊÇÑ °Í.
  • life habit
    »ýȰ ½À¼º, »ýȰ ½À°ü
    °°Àº »óȲ¿¡¼­ ¹Ýº¹µÈ ÇൿÀÇ ¾ÈÁ¤È­, ÀÚµ¿È­µÈ ¼öÇà. Á¼Àº Àǹ̷δ ¹Ýº¹¿¡ ÀÇÇÑ ±ÙÀ° ¿îµ¿À̳ª °Ç ¿îµ¿ÀÌ Á¤ÇüÈ­µÇ´Â °ÍÀ» ¸»ÇÏÁö¸¸, ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÇÏ´Â ½Ä»ç³ª ¼ö¸é ½À°ü, dz¼Ó, ¹®È­ µî ³ÐÀº °ü½À¿¡ ´ëÇØ¼­µµ ½À°üÀ̶ó°í ÇÑ´Ù. ½À°üÀ̶õ Á¤ÇüÀûÀ̸ç ÀÚµ¿ÀûÀ¸·Î ¹ß»ýÇÏ´Â ¹ÝÀÀÀ̶ó´Â Á¡¿¡¼­ ÀÚÀ¯·ÎÀÌ º¯È­ÇÏ´Â ÀǵµÀû ¹ÝÀÀ°ú ±¸º°µÈ´Ù. ¶ÇÇÑ ½À°üÀº ½ÀµæµÈ °á°ú¶ó´Â Á¡¿¡¼­ ¼±ÃµÀû ¹ÝÀÀ°ú ±¸º°µÈ´Ù. ¼ú, ´ã¹è ¶Ç´Â ƯÁ¤ ¾à¹°ÀÇ »ó¿ëÀ̳ª, ¿­´ë, ÇÑ´ë¿¡¼­ÀÇ Àå±â »ýȰ, ¿ìÁÖºñÇà¿¡¼­ÀÇ ±â¾ÐÀ̳ª ¹«Áß·Â »óÅ¿¡ ´ëÇÑ ÀûÀÀ µî Ư¼öÇÑ ¿ÜÀûÀÎ »óȲ¿¡ ´ëÇÑ ¹ÝÀÀÀÇ Á¤ÇüÈ­´Â¡®¼øÈ­¡¯¶ó°í ÇÏ¿© ½À°ü°ú ±¸º°ÇÏ¿©¾ß ÇÑ´Ù.
  • life insurance
    »ý¸í º¸Çè
    »ç¶÷ÀÇ »ç¸Á ¶Ç´Â »ýÁ¸À» º¸Çè»ç°í·Î ÇÏ´Â ÀÏüÀÇ º¸Çè. Àκ¸ÇèÀÇ ´ëÇ¥ÀûÀÎ °ÍÀÌ´Ù. º¸ÇèÀÚ°¡ º¸Çè°è¾àÀÚ ¶Ç´Â Á¦3ÀÚÀÇ »ý»ç¿¡ °üÇÏ¿© ÀÏÁ¤ÇÑ ±Ý¾×
  • life insurance medicine
    »ý¸í º¸Çè ÀÇÇÐ
  • life phase
    »ýȰ»ó
  • life span
    ¼ö¸í
    °³Ã¼ÀÇ »ýÁ¸ ±â°£.
  • life support
    »ý¸í À¯Áö
  • quality of life
    »îÀÇ Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
basic life support Emergency cardiopulmonary resuscitation, control of bleeding, treatment of shock, acidosis, and poisoning, stabilization of injuries and wounds, and basic first aid.
(05 Mar 2000)
biological half-life <biochemistry, biology> This is the time required for one-half of the total amount of a particular substance in a biological system to be consumed or broken down by biological processes when the rate of removal is approximately exponential.
Toxic chemicals with a long biological half-life (such as some pesticides) will tend to accumulate in the body and are, therefore, more likely to be harmful. A substance with a short biological half-life may still accumulate if a portion of it it becomes tightly bound to bone or other tissues, even if most of it is quickly cleared from the body.
(21 Mar 1998)
vegetative life The simple metabolic and reproductive activity of humans or animals, apart from the exercise of conscious mental or psychic processes.
(05 Mar 2000)
germ-free life Animals not contaminated by or associated with any foreign organisms.
(12 Dec 1998)
change of life Colloquialism for menopause, climacteric.
(05 Mar 2000)
RNA life <biology, molecular biology> A hypothetical life form lacking DNA and protein which may have existed on early earth and in which RNA served both a genetic coding and a catalytic function.
(23 Aug 1998)
physical half-life The time required for half the atoms of a radionuclide to undergo disintegration.
(05 Mar 2000)
wrongful life In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.
(12 Dec 1998)
postnatal life That interval of life after birth; in man, usually divided into periods: neonatal, infancy, childhood, adolescence, and adulthood.
(05 Mar 2000)
half-life 1. <pharmacology> The period over which the concentration of a specified chemical or drug takes to fall to half its original concentration in the specified fluid or blood.
2. <radiobiology> The time required to reduce the amount of a radionuclide to one-half the amount originally present. Physical or radioactive half-life refers to reduction of activity by radioactive decay, biological half-life refers to biological elimination from the body and effective half-life refers to the combined action of radioactive decay and biological elimination.
(16 Dec 1997)
prenatal life That interval of life between conception and birth; in humans, usually divided into embryonic and foetal periods.
(05 Mar 2000)
sexual life In psychiatry and psychoanalysis, the specifically erotic or sexual interests, fantasies, inclinations, and conduct of the patient.
(05 Mar 2000)
direct life cycle <epidemiology> A life cycle in which a parasite is transmitted directly from one host to the next without an intermediate host or vector of another species.
(05 Dec 1998)
drug half-life The amount of time it takes for one-half of an administered drug to be lost through biological processes (metabolism and elimination).
(27 Sep 1997)
immediately dangerous to life concentration <radiobiology> This is a regulatory value defined as the maximum exposure concentration in the workplace from which one could escape within 30 minutes without suffering symptoms which would interfere with escaping and without suffering any irreversible health effects.
(04 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • life annuity
    Á¾½Å¿¬±Ý
  • life assurance
    »ý¸íº¸Çè
  • life belt
    ±¸¸í´ë
  • life buoy
    ±¸¸í ºÎ³¶
  • life expectancy
    Æò±Õ ¿¹»ó ¼ö¸í
  • life force
    =ELAN VITAL
  • life history
    ÀÏ»ý;»ý¾Ö;(°³Ã¼ÀÇ ¹ß»ý¿¡¼­ Á×À½±îÁöÀÇ)»ýȰ»ç
  • life insurance
    »ý¸íº¸Çè(ÀǷẸÇè±Ý,º¸Çè·á)
  • life jacket
    ±¸¸í ÀÚÄÏ
  • life line
    ±¸¸í»è;»ý¸í¼±
  • life master
    ºê¸®Áö °æ±â¿¡¼­ ÃÖ°íÀÇ Á¡¼ö¸¦ µý ¼±¼ö
  • life net
    (¼Ò¹æ¿ëÀÇ) ±¸¸í¸Á
  • life office
    »ý¸íº¸Çèȸ»ç
  • life peer
    ÀÏ´ë ±ÍÁ·
  • life policy
    »ý¸íº¸ÇèÁõ¼­
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á